Skip to main content
    E

    Encompass Health Corp (EHC)

    Official site

    HEALTHCARE • MEDICAL CARE FACILITIES • NYSE

    $142.17
    +1.18 (+0.84%)

    Market Cap: $13.83B

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Encompass Health Corp (EHC) Earnings: Report Dates and Results

    Updated Oct 28, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Encompass Health (EHC) is expected to report earnings on Feb 3, 2027. In the quarter ended Sep 30, 2026, Encompass Health reported EPS of $1.52, above the $1.37 estimate. It beat the EPS estimate in each of the last 17 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    88%(35/40)
    Avg Surprise
    +9.35%
    Streak
    17 Q

    Upcoming Estimates

    Reports Feb 3, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus$1.62
    Range$1.42 - $1.74
    14 analysts
    Revenue Consensus
    $1.69B
    Range$1.49B - $1.78B
    13 analysts
    Reports Apr 28, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus$1.70
    Range$1.61 - $1.75
    8 analysts
    EPS Revisions
    1
    3
    30d
    EPS Estimate DriftChange to current
    90d ago$1.70-0.3%
    60d ago$1.71-0.8%
    30d ago$1.71-0.7%
    7d ago$1.71-0.7%
    Current$1.70
    Revenue Consensus
    $1.71B
    Range$1.70B - $1.72B
    7 analysts

    Next Report

    EHC has an expected report date of Feb 3, 2027. Analysts' consensus for the quarter ending Dec 31, 2026 is 11.0% above the $1.46 reported for the quarter ended Dec 31, 2025.

    EHC Earnings Call

    The latest EHC earnings call transcript on file is labeled 2026Q3.

    Read the 2026Q3 transcript

    Earnings History

    Of the 40 quarters below that had an estimate, EHC beat 35 and missed 5. Revenue for the quarter ended Sep 30, 2026 was $1.61B, up 8.8% from $1.48B a year earlier.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026$1.52$1.37$1.25 - $1.41+10.95%Beat+23.6%128 up, 4 downOct 28, 2026$1.61B
    Jun 30, 2026$1.55$1.48$1.42 - $1.51+4.73%Beat+10.7%121 up, 1 downAug 5, 2026$1.60B
    Mar 31, 2026$1.60$1.49$1.38 - $1.53+7.38%Beat+16.8%12N/AApr 30, 2026$1.59B
    Dec 31, 2025$1.46$1.30$1.23 - $1.35+12.31%Beat+24.8%123 up, 5 downFeb 5, 2026$1.54B
    Sep 30, 2025$1.23$1.19$1.15 - $1.23+3.36%Beat+19.4%137 up, 2 downOct 29, 2025$1.48B
    Jun 30, 2025$1.40$1.21$1.14 - $1.31+15.70%Beat+26.1%121 up, 0 downAug 4, 2025$1.46B
    Mar 31, 2025$1.37$1.19$1.14 - $1.26+15.13%Beat+22.3%100 up, 1 downApr 24, 2025$1.46B
    Dec 31, 2024$1.17$1.02$0.96 - $1.13+14.71%Beat+23.2%13N/AFeb 6, 2025$1.41B
    Sep 30, 2024$1.03$0.94$0.89 - $1.01+9.57%Beat+19.8%130 up, 0 downOct 28, 2024$1.35B
    Jun 30, 2024$1.11$1.01$0.95 - $1.09+9.90%Beat+16.8%121 up, 0 downAug 5, 2024$1.30B
    Mar 31, 2024$1.12$0.94$0.88 - $1.01+19.15%Beat+27.3%111 up, 0 downApr 24, 2024$1.32B
    Dec 31, 2023$0.95$0.82$0.76 - $0.87+15.85%Beat+8.0%101 up, 0 downFeb 7, 2024$1.25B
    Sep 30, 2023$0.86$0.77$0.72 - $0.84+11.69%Beat+28.4%101 up, 0 downOct 26, 2023$1.21B
    Jun 30, 2023$0.95$0.74$0.70 - $0.79+28.38%Beat+6.7%120 up, 0 downAug 1, 2023$1.19B
    Mar 31, 2023$0.88$0.71$0.67 - $0.76+23.94%Beat-9.3%120 up, 0 downApr 27, 2023$1.16B
    Dec 31, 2022$0.88$0.84$0.80 - $0.87+4.76%Beat-9.3%100 up, 0 downFeb 7, 2023$1.14B
    Sep 30, 2022$0.67$0.64$0.23 - $0.72+4.69%Beat-35.0%120 up, 2 downOct 26, 2022$1.09B
    Jun 30, 2022$0.89$0.96$0.88 - $1.07-7.29%Miss-23.9%130 up, 0 downAug 1, 2022$1.06B
    Mar 31, 2022$0.97$0.92$0.80 - $1.00+5.43%Beat-7.6%121 up, 0 downApr 27, 2022$1.06B
    Dec 31, 2021$0.97$1.05$0.98 - $1.09-7.62%Miss+4.3%110 up, 0 downFeb 1, 2022$486.00M
    Sep 30, 2021$1.03$1.06$1.01 - $1.12-2.83%Miss+32.1%12N/AOct 27, 2021$1.01B
    Jun 30, 2021$1.17$0.98$0.84 - $1.02+19.39%Beat+277.4%11N/AJul 27, 2021$1.29B
    Mar 31, 2021$1.05$0.82$0.70 - $0.89+28.05%Beat+20.7%11N/AApr 27, 2021$1.23B
    Dec 31, 2020$0.93$0.85$0.82 - $0.91+9.41%Beat+9.4%14N/AJan 26, 2021$136.30M
    Sep 30, 2020$0.78$0.74$0.52 - $0.88+5.41%Beat-16.1%14N/AOct 28, 2020$1.17B
    Jun 30, 2020$0.31$0.33-$0.10 - $0.95-6.06%Miss-71.3%14N/AJul 27, 2020$1.07B
    Mar 31, 2020$0.87$0.85$0.74 - $0.93+2.35%Beat-16.3%15N/AApr 28, 2020$1.18B
    Dec 31, 2019$0.85$0.87$0.78 - $0.96-2.30%Miss+6.2%15N/AFeb 6, 2020$1.18B
    Sep 30, 2019$0.93$0.89$0.84 - $0.97+4.49%Beat+2.2%17N/AOct 28, 2019$1.16B
    Jun 30, 2019$1.08$0.97$0.95 - $1.00+11.34%Beat+9.1%16N/AJul 29, 2019$1.14B
    Mar 31, 2019$1.04$0.89$0.84 - $0.94+16.85%Beat+11.8%15N/AApr 25, 2019$1.12B
    Dec 31, 2018$0.80$0.79$0.76 - $0.85+1.27%Beat+14.3%15N/AFeb 7, 2019$1.10B
    Sep 30, 2018$0.91$0.80$0.74 - $0.82+13.75%Beat+37.9%12N/AOct 29, 2018$1.07B
    Jun 30, 2018$0.99$0.84$0.81 - $0.86+17.86%Beat+39.4%13N/AJul 25, 2018$1.07B
    Mar 31, 2018$0.93$0.81$0.78 - $0.84+14.81%Beat+32.9%13N/AApr 26, 2018$1.05B
    Dec 31, 2017$0.70$0.65$0.60 - $0.71+7.69%Beat-2.8%13N/AFeb 26, 2018$1.01B
    Sep 30, 2017$0.66$0.65N/A+1.54%Beat+1.5%N/AN/AOct 26, 2017$981.60M
    Jun 30, 2017$0.71$0.68N/A+4.41%Beat+2.9%N/AN/AJul 31, 2017$966.40M
    Mar 31, 2017$0.70$0.65N/A+7.69%Beat+14.8%N/AN/AApr 27, 2017$957.10M
    Dec 31, 2016$0.72$0.62N/A+16.13%Beat+22.0%N/AN/AFeb 21, 2017$885.30M
    Last 40 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was $5.46, up 23.3% from the year before. It was $2.67 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025$5.46+23.3%
    Dec 31, 2024$4.43+21.7%
    Dec 31, 2023$3.64+6.7%
    Dec 31, 2022$3.41-19.2%
    Dec 31, 2021$4.22+46.0%
    Dec 31, 2020$2.89-25.9%
    Dec 31, 2019$3.90+7.4%
    Dec 31, 2018$3.63+31.0%
    Dec 31, 2017$2.77+3.7%
    Dec 31, 2016$2.67N/A

    Earnings Calls

    The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 8,100 words across 16 speakers.

    CallPeriod endingWordsSpeakersTranscript
    2026Q3Sep 30, 20268,13416
    2026Q2Jun 30, 20268,09117
    2026Q1Mar 31, 20269,44315
    2025Q4Dec 31, 20258,22916
    2025Q3Sep 30, 20257,23616
    2025Q2Jun 30, 20256,50015
    2025Q1Mar 31, 20257,74314
    2024Q4Dec 31, 20247,58114

    2026Q3 Earnings Call

    Opening remarks

    Mark Miller Chief Investor Relations Officer Thank you, operator, and good morning, everyone. Thank you for joining Encompass Health's Third Quarter 2026 Earnings Call. Before we begin, if you do not already have a copy, the third quarter earnings release, supplemental information, and related Form 8-K filed with the SEC are available on our website at encompasshealth.com. On Page 2 of the supplemental information, you will find the safe harbor statements, which are also set forth in greater detail on the last page of the earnings release. During the call, we will make forward-looking statements, such as guidance and growth projections, which are subject to risks and uncertainties, many of which are beyond our control. Certain risks and uncertainties, like those relating to regulatory developments as well as volume, bad debt, and cost trends that could cause actual results to differ materially from our projections, estimates, and expectations, are discussed in the company's SEC filings, including the earnings release and related Form 8-K, the Form 10-K for the year ended December 31, 2025, and the Form 10-Q for the quarters ended March 31, 2026, June 30, 2026, and September 30, 2026, when filed. We encourage you to read them. You are cautioned not to place undue reliance on the estimates, projections, guidance, and other forward-looking information presented, which are based on current estimates of future events and speak only as of today. We do not undertake a duty to update these forward-looking statements. Our supplemental information and discussion on this call will include certain non-GAAP financial measures. For such measures, reconciliation to the most directly comparable GAAP measure is available at the end of the supplemental information, at the end of the earnings release, and as part of the Form 8-K filed yesterday with the SEC, all of which are available on our website. I would like to remind everyone that we will adhere to the one-question and one-follow-up-question rule to allow everyone to submit a question. If you have additional questions, please feel free to put yourself back in the queue. With that, I'll turn the call over to President and Chief Executive Officer, Mark Tarr.

    Mark Tarr President and CEO Thank you, and good morning, everyone. We're very pleased with our third quarter results. As revenue grew 8.9%, adjusted EBITDA increased 15.5% and adjusted EPS increased 23.6%. For the first nine months of 2026, revenue rose 9.2%, adjusted EBITDA increased 11.9% and adjusted EPS was up 17%. Based primarily on our Q3 results, we are again raising our guidance for 2026. We achieved these results while once again delivering outstanding patient outcomes. Our Q3 discharge-to-community rate was 84.7%, discharge-to-acute rate was 8.4%, and discharge-to-SNF rate was 6.2%.

    Frequently Asked Questions About EHC

    When is Encompass Health's next earnings date?

    Encompass Health's next earnings report is expected for Feb 3, 2027.

    Did EHC beat earnings estimates last quarter?

    Yes. Encompass Health reported EPS of $1.52 for the quarter ended Sep 30, 2026, above the $1.37 estimate, a 10.95% surprise.

    What EPS do analysts expect from EHC next quarter?

    The consensus EPS estimate for Encompass Health for the quarter ending Dec 31, 2026 is $1.62 from 14 analysts, with estimates from $1.42 to $1.74.

    How often does EHC beat earnings estimates?

    Encompass Health beat the EPS estimate in each of the last 17 quarters, with an average surprise of +12.48%.